Benzeno Sharon's Form 4 filing
Adaptive Biotechnologies Corp (ADPT) · filed Mar 6, 2025
- Accession no.
- 0001062993-25-004815
- Filed
- Mar 6, 2025
- Trade date
- Mar 4-5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $311.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benzeno SharonCIK 0001780854 | Officer (Chief Commercial Ofc Imm Med) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Common Stock | AGrant or awardAcquired | +109,973 | $0.00 | $0 | 437,388 | Direct | |
| Mar 5, 2025 | Common Stock | SSaleDisposed | −41,600 | $6.98 | −$290,368 | 395,788 | Direct | |
| Mar 5, 2025 | Common Stock | SSaleDisposed | −3,065 | $6.99 | −$21,424.35 | 392,723 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Common Stock | AGrant or awardAcquired | +165,027 | $0.00 | $0 | 165,027 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.